Back to News
Market Impact: 0.3
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
Source: globenewswire.com
Healthcare & BiotechCorporate Earnings
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023) in the mITT population. Participants retained 80% of GLP-1-induced weight loss, versus 67% with sham.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
More News
- Wall Street's fear gauge is ripping. Traders see it going even higher
- Yields continue to rattle investors. These sectors are most at risk if rates stay elevated
- We're downgrading this retail stock after a big comeback. Plus, AI names slide again
- Major earnings reports are due next week, but strong results may not be enough to quell market fears
- Kimberly-Clark is having its best week in four years. Here's what is propelling shares higher
- Semiconductors are out, software is in. Why that’s not about to change anytime soon